亚洲社会药学

Objective To study the drug test data protection system in foreign countries, and to foster pharmaceutical innovation and increase drug accessibility in China. Methods The development history of drug test data protection was analyzed to examine and evaluate China’s current drug test data protection system so as to offer recommendations for its improvement. Finally, the drug test data protection system in China can be officially implemented. Results and Conclusion The drug test data protection system aims to promote innovation by protecting the trial data of innovative drugs. In a broad sense, this belongs to intellectual property protection, but it is different from patent protection. Although China has established a drug testing data protection system after joining the “Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)”, the relevant provisions and regulations have not yet been formally formed, and the system has not yet been implemented. Therefore, some suggestions for improving China’s drug testing data protection system are proposed to achieve good social benefits.